Board of Directors

Kelly Girskis, PhD, Investment Director, abrdn Healthcare Investors

Dr. Kelly Girskis is an Investment Director at abrdn and is responsible for equity research for the abrdn healthcare funds. She joined the firm in October 2023 following the acquisition of Tekla Capital Management where she served as Vice President, Research with a focus on private and public biotechnology investments. Previously, she held positions at SVB Leerink and Ascentia Asset Management. Dr. Girskis earned her B.A. in Neuroscience from the University of Southern California and Ph.D. in Neurobiology from Harvard University.